NASDAQ:NCTYThe9 Stock Price, Forecast & News

The9's stock was trading at $0.6387 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NCTY stock has increased by 22.1% and is now trading at $0.78. View which stocks have been most impacted by Coronavirus.

The9's stock reverse split before market open on Wednesday, May 9th 2018. The 1-3 reverse split was announced on Tuesday, May 8th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 8th 2018. An investor that had 100 shares of The9 stock prior to the reverse split would have 33 shares after the split.

News headlines about NCTY stock have been trending very negative on Thursday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. The9 earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about The9.

The9 saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 21,600 shares, a decline of 63.3% from the May 31st total of 58,800 shares. Based on an average trading volume of 159,500 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.1% of the company's stock are short sold. View The9's Current Options Chain.

Some companies that are related to The9 include Marchex (MCHX), InnerWorkings (INWK), OmniComm Systems (OMCM), Research Solutions (RSSS), Heritage Global (HGBL), Solbright Group (SBRT), Steel Connect (STCN), DynTek (DYNE), Dale Jarrett Racing Adventure (TVMD), Weyland Tech (WEYL), ALJ Regional (ALJJ), BSQUARE (BSQR), SPAR Group (SGRP), Protagenic Therapeutics (PTIX) and PeerStream (PEER). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Anavex Life Sciences (AVXL), Gevo (GEVO), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Sangamo Therapeutics (SGMO), Verizon Communications (VZ), Advanced Micro Devices (AMD), AVEO Pharmaceuticals (AVEO) and Axsome Therapeutics (AXSM).

The9 trades on the NASDAQ under the ticker symbol "NCTY."

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NCTY stock can currently be purchased for approximately $0.78.

The9 has a market capitalization of $23.74 million and generates $50,000.00 in revenue each year. The9 employs 105 workers across the globe.

The official website for The9 is www.the9.com.

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 86-21-5172-9999 or via email at [email protected]